The clinical significance of asymmetric dimethylarginine.
about
The T1405N carbamoyl phosphate synthetase polymorphism does not affect plasma arginine concentrations in preterm infants.Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis.Differential sensitivity of basal and acetylcholine-induced activity of nitric oxide to blockade by asymmetric dimethylarginine in the rat aortaPlasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring CohortQuantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry.Significance of nitric oxide and its modulation mechanisms by endogenous nitric oxide synthase inhibitors and arginase in the micturition disorders and erectile dysfunction.Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patientsThe transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro.The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.Cellular ADMA: regulation and action.The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries, and reduces blood pressure in salt-induced hypertension.The L-arginine/NO pathway, homoarginine, and nitrite-dependent renal carbonic anhydrase activity in young people with type 1 diabetes mellitus.Targeted metabolome profiling by dual-probe microdialysis sampling and treatment using Gardenia jasminoides for rats with type 2 diabetes.Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertensionRole of the human erythrocyte in generation and storage of asymmetric dimethylarginine.Analysis of arginine and methylated metabolites in human plasma by field amplified sample injection capillary electrophoresis tandem mass spectrometry.Hypothermic renal perfusion during aortic surgery reduces the presence of lipocalin-2 and preserves renal extraction of dimethylarginines in rats.Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia.The influence of acute renal injury on arginine and methylarginines metabolism.Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction.Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free L-arginine in humans.Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine.Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study.Increased asymmetric dimethylarginine concentrations in stimulated peripheral blood mononuclear cells.Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans.PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized miceSerum Asymmetric Dimethylarginine Concentrations in Two Models of Experimentally Induced Hypertension
P2860
Q33593142-63B53037-F86F-4913-8E51-BDAC01F72F0AQ33811643-72CDAF4B-6512-45D4-A907-AFD9507566CCQ34124852-2779B04C-56E6-43D0-8565-0F632307F2EFQ34448584-F12D894F-5AF8-4A1B-BE87-2B0E40C51622Q35572566-28AA7DA6-58F4-4027-BA6F-0666B023C1BFQ36982670-1404259E-45C6-44F3-B08B-3DB783231519Q37082856-E7C3A326-BCBE-4CB1-801A-C424C6D35B9CQ37206251-B2226438-5C84-422D-A029-503CBF7107A3Q37296720-593823C6-7969-46C8-AAEF-63C4166288F1Q37313734-4C6E466F-411D-4700-93C4-16AF752F2FF1Q37399711-1E521906-8584-449C-B387-F78BB8DF057EQ37798082-11F021D3-6D4A-4DDD-81B2-8B9151870D9AQ39814323-DAB9DCDC-7665-4613-A9D4-C585969BDCFDQ40783699-3B62B2B8-CDA7-4583-8F49-EF472781C7AAQ41580989-B2124B64-D672-49DB-A971-ABC7B581C085Q42174480-A164AA16-9C0C-40BA-9853-547A260E7964Q42502690-B0F6C2F4-C552-4ABC-9FA4-83A8A30FEA25Q43078663-E8F841A7-C4E2-4AA7-B70F-38D66F971B53Q45263239-E7BFAB60-42EF-42D4-A769-D3223A59EB95Q45937731-457A23A7-3927-43D7-B44A-00CB3D96E810Q45953260-77665DED-AFF3-4DAC-88CB-56BDD74040EEQ46609458-78F7C49A-2CB9-4107-A99B-A131E09A393CQ46972648-F9FF6EE4-2A3C-4AD9-B555-083DB7CC3249Q47919582-09BEA061-48BC-49C0-A338-A5EF668AF48FQ49887672-0768626F-6194-4D9E-B62C-7ABA43468BD7Q50584390-00E146FF-38D9-4332-BECD-8B3535FA6F9BQ50783438-64D0527E-BC2A-4FE5-BF0A-F21220CCD158Q51158383-07813D04-4221-46E7-A1BA-9E935FDA09E0Q51506465-05AE886E-D730-4128-8AE3-6A8A357FA169Q53550832-C52529BC-ED34-47DE-B40F-9DDA5FE84924Q53798961-AC843191-7593-47ED-B5E8-A8165C8940F5Q58699564-6817BC44-E11A-4EAB-A109-9DC0DC37C923Q58996231-DC834CBE-D602-41FF-8786-27196DFFBE0E
P2860
The clinical significance of asymmetric dimethylarginine.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The clinical significance of asymmetric dimethylarginine.
@ast
The clinical significance of asymmetric dimethylarginine.
@en
type
label
The clinical significance of asymmetric dimethylarginine.
@ast
The clinical significance of asymmetric dimethylarginine.
@en
prefLabel
The clinical significance of asymmetric dimethylarginine.
@ast
The clinical significance of asymmetric dimethylarginine.
@en
P2093
P1476
The clinical significance of asymmetric dimethylarginine.
@en
P2093
Hubert A Prins
Michiel P C Siroen
Milan C Richir
Paul A M van Leeuwen
Robert J Nijveldt
Tom Teerlink
P304
P356
10.1146/ANNUREV.NUTR.26.061505.111320
P407
P577
2006-01-01T00:00:00Z